Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 28,472

Document Document Title
WO/2015/010655A1
Triadic fused cyclic carboxylic acids derivatives, preparation method therefor and pharmaceutical use thereof, particularly relating to compounds represented by general formula (I), stereoisomers, hydrates, solvates, metabolites, eutecti...  
WO/2015/011614A1
An organic compound represented by General Formula (G1) that emits blue light with high color purity and has a long lifetime is provided as a novel substance. The organic compound is a fluorescent organic compound having a structure in w...  
WO/2015/013456A1
Provided herein are pH indicator compounds that optionally include one or more indicator compounds of Formulas (I)-(IV). Also provided are implantable medical devices to which the reaction product of the indicator compounds of Formula (I...  
WO/2015/007601A1
The invention relates to continuous process for the production of a valuable compound from a lignocellulosic biomass, said process comprising: subjecting a slurried lignocellulosic biomass to an acid hydrolysis reaction in a reactor havi...  
WO/2015/006893A1
The present invention relates to uses of a sesquiterpene lactone compound and a derivative thereof in preparation of drugs, relates to the technical field of drugs, specially relates to uses of a formula (I) compound in preparation of dr...  
WO/2015/009076A1
The present invention relates to a specific combination of a dopant compound comprising an amino-pyrene and a host compound comprising a di-aryl subsituted anthracene, and an organic electroluminescent device comprising the same. The org...  
WO/2015/004273A1
The present invention relates to a method for the effective conversion of one or more mono-, di-, oligo- or polysaccharides to hydroxymethylfurfural (HMF), in an ionic liquid by means of a chromium catalyst mixture comprising chromium (I...  
WO/2015/006715A1
The present invention provides dehydroleucodine derivatives. In particular, the present invention provides amine derivatives of dehydroleucodine and methods of using dehydroleucodine and the amine derivatives of dehydroleucodine to inhib...  
WO/2015/002230A1
The present invention relates to compounds (I), which have RORγt inhibitory effects, and salts thereof. In formula (I), each notation is as described in the Specification. (I)  
WO/2015/001422A3
Embodiments of the present disclosure provide for an aromatic dianhydride, a method of making an aromatic dianhydride, an aromatic dianhydride-based polyimide, a method of making an aromatic dianhydride-based polyimide, and the like,  
WO/2015/000070A1
Disclosed is a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, R7, R7', R8, R9, R10, R11, R12 and R13 are as disclosed herein. Also, disclosed is a process for the preparation of the co...  
WO/2015/003166A1
The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A) : or a pharmaceutically acceptable salt thereof, wherein the va...  
WO/2015/002208A1
A compound characterized by being represented by general formula (1). In general formula (1), n is 1 or 2. Ar1 is represented by general formula (2). Ar2 is a substituted or un-substituted aromatic hydrocarbon group having 6-30 carbons, ...  
WO/2015/000412A1
The present invention relates to a benzocyclobutene derivative and a preparation method and pharmaceutical application thereof. Specifically, the present invention relates to a compound expressed by formula (I) or a stereoisomer, hydrate...  
WO/2014/205592A1
Compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV in...  
WO/2014/207764A1
An efficient, hydrogen gas-free, high yielding, moderate temperature and safe-to-handle process for producing furan and its derivatives from furfural, which comprises contacting furfural and water-isopropanol mixture with a supported Pd ...  
WO/2014/205593A1
Disclosed are compounds of formula (I) that are useful as hepatitis C virus (HCV) NSSB polymerise inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NSSB polymerise activity, for treating or pre...  
WO/2014/208132A1
Provided are: a compound that contains a phenolic hydroxyl group and that has superior thermal resistance and flame resistance of the cured product thereof; a phenolic resin containing the compound that contains a phenolic hydroxyl group...  
WO/2014/209112A1
The invention is directed to a process for the preparation of 2,5- furandicarboxylic acid (FDCA) by fermentation comprising fermenting a suitable starting compound to produce an aqueous solution of a salt of FDCA having a pH of at least ...  
WO/2014/203541A1
The purpose of the present invention is to provide an organic EL element which has a long service life, while achieving a lower driving voltage. An aromatic amine derivative according to the present invention is represented by formula (1...  
WO/2014/204175A1
The present invention relates to a crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) and a method for preparing the same. The crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) according...  
WO/2014/203058A1
The present invention relates to a process for preparing Dronedarone or its pharmaceutically acceptable salts thereof, by reacting 5-amino-3-[4-(3-di-n-butyl aminopropoxy)benzoyl]-2-n-butyl benzofuran or a salt thereof with methanesulfon...  
WO/2014/199306A3
A process is described for the preparation of 5-hydroxymethylfurfural (HMF), which comprises the following steps: provision or preparation of a starting mixture, comprising one, two or more starting compounds selected from the group cons...  
WO/2014/197991A1
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/198123A1
The present invention relates to the field of natural pharmaceutical chemistry, specifically to a resveratrol dimer, (7R, 8R)-trans-delta-viniferin (I), a preparation method therefor and the use thereof in reducing blood sugar. High-spee...  
WO/2014/197991A8
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/198057A1
Disclosed is a process for the production of furanic compound comprising at least one amine function, comprising reacting a furanic compound having at least one hydroxyl function or at least one aldehyde function with a second reactant h...  
WO/2014/196491A1
[Problem] To provide a method for producing a (2R)-2-fluoro-2-C-methyl-D-ribono-γ-lactone. [Solution] A 2-fluoro-2-halopropionic acid derivative and a D-glyceraldehyde derivative are subjected to a Reformatsky reaction using an activate...  
WO/2014/197514A1
The present disclosure generally relates to the production of fuels, gasoline additives, and/or lubricants, and precursors thereof. The compounds used to produce the fuels, gasoline additives, and/or lubricants, and precursors thereof ma...  
WO/2014/194957A1
The present invention relates to new compounds according to formula (I). Said compounds are particularly useful for the improvement of organic electronic devices where the compounds according to the present invention are used e.g. as dop...  
WO/2014/195972A1
A regioselective N-Heterocyclic Carbene (NHC) catalyzed one step process for high yield synthesis of α-acyloxy carbonyl compounds is disclosed.  
WO/2014/193635A1
Plasticizers comprising a dialkyl 2,5-furandicarboxylate and plasticized polymeric compositions comprising such plasticizers. Such plasticized polymeric compositions can be employed in forming various articles of manufacture, such as coa...  
WO/2014/194209A1
Disclosed herein are compounds having a formula: or a pharmaceutically acceptable salt thereof, as well as therapeutic methods, medicaments, and compositions related thereto.  
WO/2014/193033A1
The present invention relates to a compound, an organic light emitting element comprising the same, and a display device comprising the organic light emitting element. The present invention provides a compound for an organic optoelectron...  
WO/2014/192023A1
The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use ...  
WO/2014/194292A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2014/187343A1
Disclosed are a benzofuran derivative, a preparation method therefor, and a medical application thereof, specifically relating to a compound represented by general formula (I), a stereoisomer thereof, a hydrate thereof, a solvate thereof...  
WO/2014/188762A1
The present invention is a radiation-sensitive resin composition which contains a polymer having a structural unit that contains an acid-cleavable group and a compound represented by formula (1). In formula (1), R1 represents a monovalen...  
WO/2014/188843A1
The purpose of the present invention is to provide a method for producing tetrahydrofuran with high reaction yield using erythritol that is a biomass or 3,4-dihydroxytetrahydrofuran that can be induced readily from erythritol as a raw ma...  
WO/2014/183211A1
Discloses is a process for preparation of a compound of formula 11, or a derivative thereof, wherein PG1 is an alcohol protecting group. Also, disclosed are intermediates and processes for their preparation. The compound of formula 11 ca...  
WO/2014/186035A1
The present application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase, metabolites thereof, and phannaceutically acceptable salts or prodrugs thereof. Al...  
WO/2014/184682A1
Provided herein is technology relating to imaging agents for positron emission tomography (PET) and particularly, but not exclusively, to a gonadotropin-releasing hormone (GnRH) antagonist radiolabeled with positron emitting nuclides and...  
WO/2014/184682A9
Provided herein is technology relating to imaging agents for positron emission tomography (PET) and particularly, but not exclusively, to a gonadotropin-releasing hormone (GnRH) antagonist radiolabeled with positron emitting nuclides and...  
WO/2014/182673A1
The present invention relates to compounds of Formula (la) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the Mas receptor, and are useful in methods of treatment and alleviation of d...  
WO/2014/180979A9
This invention relates to a new process for the synthesis of 5-hydroxymethylfurfural (HMF) from saccharides. In particular this invention relates to a new process for the dehydration of monosaccharides having 6 carbon atoms (hexoses), di...  
WO/2014/182873A1
The present disclosure provides novel furanone compounds, or pharmaceutically acceptable salts, solvates or prodrugs thereof, as Raf kinase, especially BRAF kinase, inhibitors, which are useful therapeutic agents for treatment of Raf kin...  
WO/2014/180271A1
Revealed in the present invention is a method for preparing Afatinib (I): using 2-nitrile-4-[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino- 5-[(S)- (tetrahydrofuran-3-yl)oxy]aniline (II) and 4-fluoro-3-chloroaniline (III) as starting ma...  
WO/2014/180979A1
This invention relates to a new process for the synthesis of 5-hydroxymethylfurfural (HMF) from saccharides. In particular this invention relates to a new process for the dehydration of monosaccharides having 6 carbon atoms (hexoses), di...  
WO/2014/182244A1
The present invention provides a polymer comprising an aliphatic backbone having a plurality of aromatic rings bonded thereon, said plurality of aromatic rings comprising a first aromatic ring type that has an alkyl halide group substitu...  
WO/2014/182688A1
The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the Mas receptor, and are useful in methods of treatment and alleviation of d...  

Matches 51 - 100 out of 28,472